Effect of sacubitril/valsartan on cardiac remodeling compared with other renin –angiotensin system inhibitors: a difference-in-difference analysis of propensity-score matched samples

ConclusionIn HFrEF patients treated with beta-blockers, sacubitril/valsartan is associated with a relative greater benefit in LV reverse remodeling indices than other RAS inhibitors.Graphical abstract
Source: Clinical Research in Cardiology - Category: Cardiology Source Type: research